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Background
Myocardial longitudinal relaxation time (T1, ms) is a
fundamental magnetic property of tissue that is related
to water content and mobility. The pathophysiological
and prognostic importance of native myocardial T1
values in acute ST-elevation myocardial infarction
(STEMI) patients is unknown. We aimed to assess the
clinical significance of infarct core native T1.
Methods
We performed a prospective single center cohort study
in reperfused STEMI patients who underwent CMR 2
days and 6 months post-MI. Native T1 CMR (MOLLI
investigational prototype sequence: 3 (3) 3 (3) 5) was
measured in myocardial regions-of-interest. The infarct
territory and microvascular obstruction (MVO) were
depicted with late gadolinium enhancement CMR.
Adverse remodeling was defined as an increase in LV
end-diastolic volume (LVEDV) ≥ 20% at 6 months. All-
cause death or heart failure hospitalization was a pre-
specified outcome that was assessed during follow-up.
Results
300 STEMI patients (mean±SD age 59±12 years, 74%
male, 114 with anterior STEMI) gave informed consent
and had CMR (14 July 2011 - 22 November 2012). Of
these, 288 STEMI patients had evaluable T1 maps. Infarct
size was 18 ±14% of LV mass. One hundred and forty five
(50%) of 288 patients had late MVO, whereas 160 (56%)
patients had infarct core pathology revealed by native T1.
Native T1 within the infarct core (996.9±57.3; p<0.01) was
higher than in the remote zone (961±25 ms; p<0.01) but
lower than in the area-at-risk (1097 ±52 ms). In multivari-
able linear regression, native T1 in the infarct core was
negatively associated with age, initial systolic blood pres-
sure, TIMI coronary flow grade at initial angiography,
Killip class at presentation and neutrophil count (all
p<0.05), independent of LVEF, LVEDV or infarct size.
At 6 months, LVEDV increased by 5 (25) ml (n=262
patients with evaluable data). Adverse remodeling
occurred in 30 (12%) patients and 23 (76.7%) of these
patients MVO at baseline. T1 in the infarct core was a
multivariable predictor of adverse remodeling (-0.01
(-0.02, -0.00); p=0.048).
288 (100%) patients were followed-up for a median of
845 days. Thirty (10.4%) patients died or experienced a
heart failure event and 13 (4.5%) of these patients experi-
enced the event post-discharge. Infarct core native T1 pre-
dicted all-cause death or heart failure post-discharge
(hazard ratio 0.969, 95% CI 0.953, 0.985; p<0.001) includ-
ing after adjustment for LVEF (p<0.001) and LVEDV at
baseline (p<0.001), and was comparable with MVO.
Conclusions
Infarct core native T1 represents a novel alternative
non-contrast imaging biomarker for infarct characteriza-
tion and prognostication in STEMI survivors.
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Figure 1 Three patients with acute STEMI treated by primary PCI. Cardiac MRI was performed for each patient 2 days later. (a) Patient with no T1
hypointense infarct core and no microvascular obstruction. Six month follow-up MRI revealed final infarct size was 15.6% of left ventricular mass
and left ventricular end-diastolic volume (LVEDV) reduced was reduced vs. baseline scan. This patient had an uncomplicated clinical course. (b)
Patient with both T1 hypointense infarct core and microvascular obstruction. Six month follow-up MRI revealed final infarct size was 22.6% of left
ventricular mass and an increased LVEDV. During follow-up this patient was hospitalized for new onset heart failure. (c) Patient with T1
hypointense infarct core, but no microvascular obstruction. Six month follow-up MRI revealed final infarct size was 22.1% of left ventricular mass
and a significantly increased LVEDV. No adverse events during follow-up.
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